Abemaciclib (LY2835219) is a dual inhibitor of CDK4/6 (IC50=2/10 nM) with selectivity and specificity. Abemaciclib has antitumor activity and is used to treat advanced or metastatic breast cancer.
Molecular Weight:
506.59
CAS Number:
[1231929-97-7]
Formula:
C27H32F2N8
Target:
LY2835219 , CDK4/6 dual inhibitor
* VAT and and shipping costs not included. Errors and price changes excepted